UCBJF:OTCMKTS
UCB SA
၂၃၉.၁၄ US$
arrow_downward
-၀.၄၆%(-၁.၁၀) 1D
အောက် ၁၆, GMT-၄ ၁၆:၀၀:၀၀ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for UCBJF...
Open
၂၃၉.၁၄ US$
High
၂၃၉.၁၄ US$
Low
၂၃၉.၁၄ US$
Mkt. cap
ဋေ ၃.၉၄ ထ
Avg. vol.
၁၂၇.၀၀
Volume
၁၀၇.၀၀
52-wk high
၃၄၅.၃၉ US$
52-wk low
၂၁၉.၆၀ US$
Beta
၀.၅၈
Shares outstanding
၁၉.၄၅ ကုဋေ
No. of employees
၉ ထောင်
Open
၂၃၉.၁၄ US$
High
၂၃၉.၁၄ US$
Low
၂၃၉.၁၄ US$
Mkt. cap
ဋေ ၃.၉၄ ထ
Avg. vol.
၁၂၇.၀၀
Volume
၁၀၇.၀၀
52-wk high
၃၄၅.၃၉ US$
52-wk low
၂၁၉.၆၀ US$
Beta
၀.၅၈
Shares outstanding
၁၉.၄၅ ကုဋေ
No. of employees
၉ ထောင်
News stories
From web sources and news partners
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၂၂ မိနစ်
UCB launches Wear It Out: what it means for UCB stock
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၁ ရက်
UCB revises Bimzelx potential above EUR 7 billion: UCB stock sits 30.28 percent below its high
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၂ ရက်
UCB dedicates Georgia campus as UCB stock sits 29.15 percent below its high
Profile
UCB is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's disease, and Crohn's disease. The company's efforts are focused on treatments for severe diseases treated by specialists, particularly in the fields of central nervous system disorders, inflammatory disorders, and oncology.
Every three years, the company presents the UCB Award under the patronage of the Queen Elisabeth Medical Foundation to promote neuroscience research. The winner of this award is selected by an independent scientific committee. Wikipedia
About UCB SA